{
    "root": "6471df09-2ee1-43c4-8335-0a7a9fc5bbd4",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Losartan Potassium",
    "value": "20250520",
    "ingredients": [
        {
            "name": "LOSARTAN POTASSIUM",
            "code": "3ST302B24A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6541"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED",
            "code": "2165RE0K14"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        }
    ],
    "indications": {
        "text": "losartan potassium tablets angiotensin ii receptor blocker ( arb ) indicated : \u2022 treatment hypertension , lower blood pressure adults children greater 6 years old . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) \u2022 reduction risk stroke patients hypertension left ventricular hypertrophy . evidence benefit apply black patients . ( 1.2 ) \u2022 treatment diabetic nephropathy elevated serum creatinine proteinuria patients type 2 diabetes history hypertension . ( 1.3 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "stroke (DOID:6713)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6713"
            },
            {
                "text": "nephropathy (DOID:557)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_557"
            },
            {
                "text": "proteinuria (DOID:576)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_576"
            },
            {
                "text": "type 2 diabetes (DOID:9352)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9352"
            },
            {
                "text": "diabetes (DOID:9351)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9351"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "hypertension \u2022 usual adult dose : 50 mg daily . ( 2.1 ) \u2022 usual pediatric starting dose : 0.7 mg per kg daily ( 50 mg ) . ( 2.1 ) hypertensive patients left ventricular hypertrophy \u2022 usual starting dose : 50 mg daily . ( 2.2 ) \u2022 add hydrochlorothiazide 12.5 mg and/or increase losartan potassium 100 mg followed increase hydrochlorothiazide 25 mg blood pressure response needed . ( 2.2 , 14.2 ) nephropathy type 2 diabetic patients \u2022 usual dose : 50 mg daily . ( 2.3 ) \u2022 increase dose 100 mg daily blood pressure response needed . ( 2.3 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "nephropathy (DOID:557)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_557"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "losartan potassium tablets usp , 25 mg white off-white , capsule-shaped , film-coated tablets debossed logo `` z `` one side `` 2 `` side supplied follows : overbagged 10 film-coated tablets per bag , ndc 55154-2326-0 losartan potassium tablets usp , 50 mg white off-white , capsule-shaped , film-coated tablets debossed logo `` z16 `` one side lip type breakline side supplied follows : overbagged 10 film-coated tablets per bag , ndc 55154-2327-0 losartan potassium tablets usp , 100 mg white off-white , capsule-shaped , film-coated tablets debossed logo `` z18 `` one side plain side supplied follows : overbagged 10 film-coated tablets per bag , ndc 55154-2333-0 warning : unit dose packages child resistant intended institutional . keep drugs reach children . storage : store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) [ usp controlled room temperature ] . keep container tightly closed . protect light . dispense tight , light-resistant container .",
    "adverseReactions": "\u2022 hypersensitivity component . ( 4 ) \u2022 coadministration aliskiren patients diabetes . ( 4 )",
    "indications_original": "Losartan potassium tablets are an angiotensin II receptor blocker (ARB) indicated for: \u2022 Treatment of      hypertension, to lower blood pressure in adults and children greater than      6 years old. Lowering blood pressure reduces the risk of fatal and      nonfatal cardiovascular events, primarily strokes and myocardial      infarctions. ( 1.1 ) \u2022 Reduction of      the risk of stroke in patients with hypertension and left ventricular      hypertrophy. There is evidence that this benefit does not apply to Black      patients. ( 1.2 ) \u2022 Treatment of      diabetic nephropathy with an elevated serum creatinine and proteinuria in      patients with type 2 diabetes and a history of hypertension. ( 1.3 )",
    "contraindications_original": "Hypertension \u2022 Usual adult dose: 50 mg once      daily. ( 2.1 ) \u2022 Usual pediatric starting dose:      0.7 mg per kg once daily (up to 50 mg). ( 2.1 ) Hypertensive Patients with Left Ventricular Hypertrophy \u2022 Usual starting dose: 50 mg once      daily. ( 2.2 ) \u2022 Add hydrochlorothiazide 12.5 mg      and/or increase losartan potassium to 100 mg followed by an increase to      hydrochlorothiazide 25 mg if further blood pressure response is needed. ( 2.2 , 14.2 ) Nephropathy in Type 2 Diabetic Patients \u2022 Usual dose: 50 mg once daily. ( 2.3 ) \u2022 Increase dose to 100 mg once      daily if further blood pressure response is needed. ( 2.3 )",
    "warningsAndPrecautions_original": "Losartan Potassium Tablets USP, 25 mg are white to off-white, capsule-shaped, film-coated tablets debossed with the logo of \"Z\" on one side and \"2\"on other side and are supplied as follows:\n                  Overbagged with 10 film-coated tablets per bag,\u00a0NDC 55154-2326-0\n                  Losartan Potassium Tablets USP, 50 mg are white to off-white, capsule-shaped, film-coated tablets debossed with the logo of \"Z16\" on one side and lip type breakline on other side and are supplied as follows:\n                  Overbagged with 10 film-coated tablets per bag, NDC 55154-2327-0\n                  Losartan Potassium Tablets USP, 100 mg are white to off-white, capsule-shaped, film-coated tablets debossed with the logo of \"Z18\" on one side and plain on other side and are supplied as follows:\n                  Overbagged with 10 film-coated tablets per bag, NDC 55154-2333-0\n                  WARNING: These Unit Dose packages are not child resistant and are Intended for Institutional Use Only. Keep this and all drugs out of the reach of children.\n                  \n                     Storage:\n                  \n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F) [See USP Controlled Room Temperature]. Keep container tightly closed. Protect from light.\n                  Dispense in a tight, light-resistant container.",
    "adverseReactions_original": "\u2022 Hypersensitivity to any      component. ( 4 ) \u2022 Coadministration with aliskiren      in patients with diabetes. ( 4 )",
    "drug": [
        {
            "name": "Losartan Potassium",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6541"
        }
    ]
}